作者: Edyta Szymańska , Rafał Kisielewski , Jarosław Kierkuś
DOI: 10.1016/J.JOGOH.2020.101777
关键词:
摘要: Inflammatory bowel diseases (IBD) affect mainly young population. Therefore, fertility and pregnancy are important clinical issues to be considered. Generally, in IBD patients is not decreased either males or females when compared a healthy Moreover, drugs used for treatment do significantly humans. However, prolonged with sulphasalazine may reduce semen quality cause reversible infertility. Since the disease course risk of pregnancy-related complications depend on activity at time conception, female should plan their during remission phase. Methotrexate, mycophenolate mofetil thalidomide strongly contraindicated pregnancy. Other medications seem safe provided that they administered caution. In 2015, European Crohn's Colitis Organisation (ECCO) published its Consensus Reproduction Pregnancy IBD. management reproductive age still remains controversial, since evidence-based data come mostly from retrospective studies. The aim this paper was discuss issue reproduction based current ECCO guidelines literature.